These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 11953899)
1. Gamma-heregulin has no biological significance in primary breast cancer. Sánchez-Valdivieso EA; Cruz JJ; Salazar R; del Mar Abad M; Gómez-Alonso A; Gómez A; González-Sarmiento R Br J Cancer; 2002 Apr; 86(8):1362-3. PubMed ID: 11953899 [No Abstract] [Full Text] [Related]
2. gamma-heregulin is the product of a chromosomal translocation fusing the DOC4 and HGL/NRG1 genes in the MDA-MB-175 breast cancer cell line. Wang XZ; Jolicoeur EM; Conte N; Chaffanet M; Zhang Y; Mozziconacci MJ; Feiner H; Birnbaum D; Pébusque MJ; Ron D Oncogene; 1999 Oct; 18(41):5718-21. PubMed ID: 10523851 [TBL] [Abstract][Full Text] [Related]
3. Gamma-heregulin: a fusion gene of DOC-4 and neuregulin-1 derived from a chromosome translocation. Liu X; Baker E; Eyre HJ; Sutherland GR; Zhou M Oncogene; 1999 Nov; 18(50):7110-4. PubMed ID: 10597312 [TBL] [Abstract][Full Text] [Related]
4. A recurrent chromosome translocation breakpoint in breast and pancreatic cancer cell lines targets the neuregulin/NRG1 gene. Adélaïde J; Huang HE; Murati A; Alsop AE; Orsetti B; Mozziconacci MJ; Popovici C; Ginestier C; Letessier A; Basset C; Courtay-Cahen C; Jacquemier J; Theillet C; Birnbaum D; Edwards PA; Chaffanet M Genes Chromosomes Cancer; 2003 Aug; 37(4):333-45. PubMed ID: 12800145 [TBL] [Abstract][Full Text] [Related]
5. Neuregulin: a cut-and-pasted cancer gene? Bradbury J Drug Discov Today; 2003 Oct; 8(19):865-6. PubMed ID: 14554006 [No Abstract] [Full Text] [Related]
6. Analysis of the candidate 8p21 tumour suppressor, BNIP3L, in breast and ovarian cancer. Lai J; Flanagan J; Phillips WA; Chenevix-Trench G; Arnold J Br J Cancer; 2003 Jan; 88(2):270-6. PubMed ID: 12610513 [TBL] [Abstract][Full Text] [Related]
7. Loss of heterozygosity at microsatellite markers from region p11-21 of chromosome 8 in microdissected breast tumor but not in peritumoral cells. Charafe-Jauffret E; Moulin JF; Ginestier C; Bechlian D; Conte N; Geneix J; Adélaïde J; Noguchi T; Hassoun J; Jacquemier J; Birnbaum D Int J Oncol; 2002 Nov; 21(5):989-96. PubMed ID: 12370745 [TBL] [Abstract][Full Text] [Related]
8. Heregulin and retinoids synergistically induce branching morphogenesis of breast cancer cells cultivated in 3D collagen gels. Offterdinger M; Schneider SM; Grunt TW J Cell Physiol; 2003 May; 195(2):260-75. PubMed ID: 12652653 [TBL] [Abstract][Full Text] [Related]
9. UQCRH gene encoding mitochondrial Hinge protein is interrupted by a translocation in a soft-tissue sarcoma and epigenetically inactivated in some cancer cell lines. Modena P; Testi MA; Facchinetti F; Mezzanzanica D; Radice MT; Pilotti S; Sozzi G Oncogene; 2003 Jul; 22(29):4586-93. PubMed ID: 12881716 [TBL] [Abstract][Full Text] [Related]
10. Morphologic characterization of acute myeloid leukemia with cytogenetic or molecular evidence of t(8;21), t(15;17), inv(16) and 11q23 abnormalities. Rozman M; Navarro JT; Domingo A; Ayats R; Vallespí T; Gallart M; Florensa L; Haematologica; 2002 Aug; 87(8):886-7. PubMed ID: 12161368 [No Abstract] [Full Text] [Related]
11. Cloning of BCAS3 (17q23) and BCAS4 (20q13) genes that undergo amplification, overexpression, and fusion in breast cancer. Bärlund M; Monni O; Weaver JD; Kauraniemi P; Sauter G; Heiskanen M; Kallioniemi OP; Kallioniemi A Genes Chromosomes Cancer; 2002 Dec; 35(4):311-7. PubMed ID: 12378525 [TBL] [Abstract][Full Text] [Related]
12. Heregulin up-regulates heat shock protein-70 expression in breast cancer cells. Mandal M; Li F; Kumar R Anticancer Res; 2002; 22(4):1965-9. PubMed ID: 12174871 [TBL] [Abstract][Full Text] [Related]
13. The human ovarian teratocarcinoma cell line PA-1 demonstrates a single translocation: analysis with fluorescence in situ hybridization, spectral karyotyping, and bacterial artificial chromosome microarray. Sarraf S; Tejada R; Abawi M; Oberst M; Dennis T; Simon KC; Blancato J Cancer Genet Cytogenet; 2005 Aug; 161(1):63-9. PubMed ID: 16080959 [TBL] [Abstract][Full Text] [Related]
14. Heregulin is sufficient for the promotion of tumorigenicity and metastasis of breast cancer cells in vivo. Atlas E; Cardillo M; Mehmi I; Zahedkargaran H; Tang C; Lupu R Mol Cancer Res; 2003 Jan; 1(3):165-75. PubMed ID: 12556556 [TBL] [Abstract][Full Text] [Related]
15. Skin-type hidradenoma of the breast parenchyma with t(11;19) translocation: hidradenoma of the breast. Kazakov DV; Vanecek T; Belousova IE; Mukensnabl P; Kollertova D; Michal M Am J Dermatopathol; 2007 Oct; 29(5):457-61. PubMed ID: 17890914 [TBL] [Abstract][Full Text] [Related]
16. A deletion mutant of heregulin increases the sensitivity of breast cancer cells to chemotherapy without promoting tumorigenicity. Atlas E; Bojanowski K; Mehmi I; Lupu R Oncogene; 2003 May; 22(22):3441-51. PubMed ID: 12776196 [TBL] [Abstract][Full Text] [Related]
17. Reciprocal translocations in breast tumor cell lines: cloning of a t(3;20) that targets the FHIT gene. Popovici C; Basset C; Bertucci F; Orsetti B; Adélaide J; Mozziconacci MJ; Conte N; Murati A; Ginestier C; Charafe-Jauffret E; Ethier SP; Lafage-Pochitaloff M; Theillet C; Birnbaum D; Chaffanet M Genes Chromosomes Cancer; 2002 Nov; 35(3):204-18. PubMed ID: 12353263 [TBL] [Abstract][Full Text] [Related]
18. Choline kinase activation is a critical requirement for the proliferation of primary human mammary epithelial cells and breast tumor progression. Ramírez de Molina A; Báñez-Coronel M; Gutiérrez R; Rodríguez-González A; Olmeda D; Megías D; Lacal JC Cancer Res; 2004 Sep; 64(18):6732-9. PubMed ID: 15374991 [TBL] [Abstract][Full Text] [Related]
19. Molecular cytogenetic analysis of breast cancer: a combined multicolor fluorescence in situ hybridization and G-banding study of uncultured tumor cells. Ferti AD; Stamouli MJ; Panani AD; Raptis SA; Young BD Cancer Genet Cytogenet; 2004 Feb; 149(1):28-37. PubMed ID: 15104280 [TBL] [Abstract][Full Text] [Related]
20. Heregulin-triggered Her-2/neu signaling enhances nuclear accumulation of p21WAF1/CIP1 and protects breast cancer cells from cisplatin-induced genotoxic damage. Menendez JA; Mehmi I; Lupu R Int J Oncol; 2005 Mar; 26(3):649-59. PubMed ID: 15703820 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]